Digestives & Intestinal Remedies - Southeast Asia

Southeast Asia

Highlights

In Southeast Asia, the Digestives & Intestinal Remedies market market generated a revenue of US$1.04bn in 2024.
It is projected to experience an annual growth rate of 5.44% (CAGR 2024-2029).
When compared globally, China stands out as the country with the highest revenue, reaching US$4.41bn in 2024.
In terms of per capita figures, the revenue per person in 2024 amounted to US$1.51.
In Southeast Asia, the demand for digestive and intestinal remedies in the OTC Pharmaceuticals market is rapidly growing due to dietary changes and an increase in gastrointestinal disorders.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in Southeast Asia is experiencing significant growth and development.

Customer preferences: Customers in Southeast Asia have shown a growing interest in digestive health and are increasingly seeking remedies to address digestive issues. This can be attributed to several factors, including changing dietary habits, stressful lifestyles, and a rising awareness of the importance of gut health. As a result, there is a growing demand for digestive and intestinal remedies in the region.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Southeast Asia is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious about the ingredients in the products they consume and are opting for natural alternatives. This trend is driven by a desire for healthier and more sustainable options. As a result, companies in the market are introducing a wide range of natural and herbal products to cater to this demand.Another trend in the market is the growing popularity of probiotics and prebiotics. Probiotics are live bacteria that provide health benefits when consumed, while prebiotics are non-digestible fibers that promote the growth of beneficial bacteria in the gut. These products are gaining traction in Southeast Asia as consumers become more aware of the role of gut health in overall well-being. The market is seeing a surge in the launch of probiotic and prebiotic supplements, as well as food and beverages fortified with these ingredients.

Local special circumstances: Southeast Asia is a diverse region with varying healthcare systems and cultural practices. Traditional medicine plays a significant role in many Southeast Asian countries, and consumers often rely on traditional remedies for digestive issues. This presents both opportunities and challenges for companies operating in the Digestives & Intestinal Remedies market. While there is a market for traditional remedies, companies need to navigate the regulatory landscape and gain consumer trust in order to succeed in this segment.

Underlying macroeconomic factors: The growing middle class and rising disposable incomes in Southeast Asia are driving the growth of the Digestives & Intestinal Remedies market. As people have more disposable income, they are willing to spend on healthcare products and are becoming more health-conscious. Additionally, the increasing urbanization in the region is leading to a sedentary lifestyle and unhealthy dietary habits, which in turn is fueling the demand for digestive and intestinal remedies.In conclusion, the Digestives & Intestinal Remedies market in Southeast Asia is witnessing significant growth due to changing customer preferences, including a preference for natural and herbal remedies, as well as the increasing popularity of probiotics and prebiotics. The market is also influenced by local special circumstances, such as the reliance on traditional remedies and the need to navigate diverse healthcare systems. The underlying macroeconomic factors of a growing middle class and rising disposable incomes further contribute to the development of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.